Characterization of mice lacking the multidrug resistance protein Mrp2 (Abcc2)

被引:108
作者
Chu, XY
Strauss, JR
Mariano, MA
Li, J
Newton, DJ
Cai, XX
Wang, RW
Yabut, J
Hartley, DP
Evans, DC
Evers, R
机构
[1] Merck & Co Inc, Dept Drug Metab, Rahway, NJ 07065 USA
[2] Merck & Co Inc, Lab Anim Resources, Rahway, NJ 07065 USA
关键词
D O I
10.1124/jpet.105.098665
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The multidrug resistance protein Mrp2 is an ATP-binding cassette (ABC) transporter mainly expressed in liver, kidney, and intestine. One of the physiological roles of Mrp2 is to transport bilirubin glucuronides from the liver into the bile. Current in vivo models to study Mrp2 are the transporter-deficient and Eisai hyperbilirubinemic rat strains. Previous reports showed hyperbilirubinemia and induction of Mrp3 in the hepatocyte sinusoidal membrane in the mutant rats. In addition, differences in liver cytochrome P450 and UGT1a levels between wild-type and mutant rats were detected. To study whether these compensatory mechanisms were specific to rats, we characterized Mrp2(-/-) mice. Functional absence of Mrp2 in the knockout mice was demonstrated by showing increased levels of bilirubin and bilirubin glucuronides in serum and urine, a reduction in biliary excretion of bilirubin glucuronides and total glutathione, and a reduction in the biliary excretion of the Mrp2 substrate dibromosulfophthalein. To identify possible compensatory mechanisms in Mrp2(-/-) mice, the expression levels of 98 phase I, phase II, and transporter genes were compared in liver, kidney, and intestine of male and female Mrp2(-/-) and control mice. Unlike in Mrp2 mutant rats, no induction of Mrp3 in Mrp2(-/-) mice was detected. However, Mrp4 mRNA and protein in liver and kidney were increased similar to 6- and 2-fold, respectively. Phenotypic analysis of major cytochrome P450-mediated activities in liver microsomes did not show differences between wild-type and Mrp2(-/-) mice. In conclusion, Mrp2(-/-) mice are a new valuable tool to study the role of Mrp2 in drug disposition.
引用
收藏
页码:579 / 589
页数:11
相关论文
共 41 条
[1]   Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice [J].
Assem, M ;
Schuetz, EG ;
Leggas, M ;
Sun, DX ;
Yasuda, K ;
Reid, G ;
Zelcer, N ;
Adachi, M ;
Strom, S ;
Evans, RM ;
Moore, DD ;
Borst, P ;
Schuetz, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22250-22257
[2]   Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins [J].
Ballatori, N ;
Hammond, CL ;
Cunningham, JB ;
Krance, SM ;
Marchan, R .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 204 (03) :238-255
[3]   Analysis of the in vivo functions of Mrp3 [J].
Belinsky, MG ;
Dawson, PA ;
Shchaveleva, I ;
Bain, LJ ;
Wang, RX ;
Ling, V ;
Chen, ZS ;
Grinberg, A ;
Westphal, H ;
Klein-Szanto, A ;
Lerro, A ;
Kruh, GD .
MOLECULAR PHARMACOLOGY, 2005, 68 (01) :160-168
[4]   Mammalian ABC transporters in health and disease [J].
Borst, P ;
Elferink, RO .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :537-592
[5]   Up-regulation of Mrp4 expression in kidney of Mrp2-deficient TR- rats [J].
Chen, CA ;
Slitt, AL ;
Dieter, MZ ;
Tanaka, Y ;
Scheffer, GL ;
Klaassen, CD .
BIOCHEMICAL PHARMACOLOGY, 2005, 70 (07) :1088-1095
[6]  
Chu XY, 1997, J PHARMACOL EXP THER, V281, P304
[7]   Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) [J].
Doyle, LA ;
Ross, DD .
ONCOGENE, 2003, 22 (47) :7340-7358
[8]  
Elferink RO, 2002, BBA-MOL BASIS DIS, V1586, P129
[9]   HEPATOBILIARY SECRETION OF ORGANIC-COMPOUNDS - MOLECULAR MECHANISMS OF MEMBRANE-TRANSPORT [J].
ELFERINK, RPJO ;
MEIJER, DKF ;
KUIPERS, F ;
JANSEN, PLM ;
GROEN, AK ;
GROOTHUIS, GMM .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1995, 1241 (02) :215-268
[10]  
Hirohashi T, 1998, MOL PHARMACOL, V53, P1068